Opioid Use Disorder in Women and the Implications for Treatment.


Journal

Psychiatric research and clinical practice
ISSN: 2575-5609
Titre abrégé: Psychiatr Res Clin Pract
Pays: United States
ID NLM: 101776485

Informations de publication

Date de publication:
2021
Historique:
entrez: 6 12 2021
pubmed: 7 12 2021
medline: 7 12 2021
Statut: ppublish

Résumé

The opioid epidemic continues to evolve and impact all groups of people. Moreover, there are concerning trends among women. The aim of this article is to provide a review of opioid use disorder in women and the implications for treatment. A nonsystematic review of the literature as conducted to examine: (1) the epidemiology of opioid-related hospitalizations and deaths of women; (2) co-occurring pain, anxiety disorders, and trauma among women with opioid use disorder; (3) evidence for opioid agonist treatment of pregnant women with opioid use disorder; and (4) implications for treatment of women with opioid use disorder and next steps for research and practice. The current opioid epidemic has produced important differences by sex and gender with increased rates of use and overdose deaths in women. Significant mental health concerns for women include co-occurring psychiatric disorders and suicide. Expanding medication treatment for perinatal opioid use disorder is crucial. While effective treatments exist for opioid use disorder, they are often not accessible, and a minority of patients are treated. The end to the opioid epidemic will require innovative multi-systemic solutions. There are significant practice gaps in preventing rising death rates among women by opioid overdose, treating co-occurring psychiatric disorders and pain, and treating perinatal women with opioid use disorder and their infants. Research on sex and gender differences, and the intersection with race/ethnicity and US region, is critically needed and should include treatment implementation studies to achieve wider access for women to effective prevention, early intervention, and treatment.

Identifiants

pubmed: 34870109
doi: 10.1176/appi.prcp.20190051
pmc: PMC8639162
mid: NIHMS1759526
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3-11

Subventions

Organisme : NIDA NIH HHS
ID : R34 DA046730
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA013714
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA013727
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA015831
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA013035
Pays : United States

Déclaration de conflit d'intérêts

The authors have no conflict of interest to disclose.

Références

Drug Alcohol Depend. 2014 Sep 1;142:245-53
pubmed: 25042759
N Engl J Med. 2018 Apr 26;378(17):1567-1569
pubmed: 29694805
Drug Alcohol Depend. 2017 Oct 1;179:325-329
pubmed: 28841495
Lancet. 2018 Jan 27;391(10118):309-318
pubmed: 29150198
Addict Behav. 2010 Nov;35(11):1001-7
pubmed: 20598809
Am J Drug Alcohol Abuse. 2011 Sep;37(5):301-12
pubmed: 21854272
Drug Alcohol Depend. 2019 Apr 1;197:78-82
pubmed: 30784952
Anesthesiology. 2014 Dec;121(6):1158-65
pubmed: 25405293
MMWR Morb Mortal Wkly Rep. 2019 Jan 11;68(1):1-5
pubmed: 30629574
Addiction. 2007 Mar;102(3):447-54
pubmed: 17298653
MMWR Morb Mortal Wkly Rep. 2018 Sep 14;67(36):1001-1006
pubmed: 30212442
Pediatrics. 2018 Apr;141(4):
pubmed: 29572288
Am J Drug Alcohol Abuse. 2011 Jan;37(1):43-7
pubmed: 21090958
MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):845-849
pubmed: 30091969
Cochrane Database Syst Rev. 2013 Dec 23;(12):CD006318
pubmed: 24366859
J Subst Abuse Treat. 2013 Jul;45(1):38-43
pubmed: 23313145
Am J Public Health. 2017 Mar;107(3):421-426
pubmed: 28103068
Addict Behav. 2019 Jan;88:48-55
pubmed: 30142484
N Engl J Med. 2014 May 29;370(22):2063-6
pubmed: 24758595
N Engl J Med. 2019 Jan 3;380(1):71-79
pubmed: 30601750
Psychiatr Clin North Am. 2010 Jun;33(2):339-55
pubmed: 20385341
Am J Addict. 2019 Jul;28(4):246-261
pubmed: 31131505
J Pain. 2012 Oct;13(10):988-96
pubmed: 23031398
MMWR Morb Mortal Wkly Rep. 2016 Aug 12;65(31):799-802
pubmed: 27513154
J Pain. 2016 Jul;17(7):806-14
pubmed: 27058161
N Engl J Med. 2010 Dec 9;363(24):2320-31
pubmed: 21142534
Addiction. 2016 Dec;111(12):2115-2128
pubmed: 27223595
Am J Drug Alcohol Abuse. 2012 Mar;38(2):161-5
pubmed: 22185368
Drug Alcohol Depend. 2007 Jan 5;86(1):1-21
pubmed: 16759822
Arch Gen Psychiatry. 2011 Dec;68(12):1238-46
pubmed: 22065255
J Psychiatr Res. 2011 Aug;45(8):1027-35
pubmed: 21439576
Am J Addict. 2018 Sep;27(6):465-470
pubmed: 30106494
Am J Psychiatry. 2007 Jan;164(1):100-7
pubmed: 17202550
Ann Intern Med. 2018 Mar 20;168(6):453-455
pubmed: 29204603
JAMA. 2012 Aug 15;308(7):690-9
pubmed: 22893166

Auteurs

Celestina Barbosa-Leiker (C)

College of Nursing, Washington State University, Spokane, (Barbosa-Leiker); Program of Excellence in Addictions Research, Washington State University, Spokane, (Barbosa-Leiker); Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, (Campbell); Department of Psychiatry, McLean Hospital, Harvard Medical School, Boston, Massachusetts (McHugh, Greenfield); Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Medical University of South Carolina, Charleston, (Guille).

Aimee N C Campbell (ANC)

College of Nursing, Washington State University, Spokane, (Barbosa-Leiker); Program of Excellence in Addictions Research, Washington State University, Spokane, (Barbosa-Leiker); Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, (Campbell); Department of Psychiatry, McLean Hospital, Harvard Medical School, Boston, Massachusetts (McHugh, Greenfield); Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Medical University of South Carolina, Charleston, (Guille).

R Kathryn McHugh (RK)

College of Nursing, Washington State University, Spokane, (Barbosa-Leiker); Program of Excellence in Addictions Research, Washington State University, Spokane, (Barbosa-Leiker); Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, (Campbell); Department of Psychiatry, McLean Hospital, Harvard Medical School, Boston, Massachusetts (McHugh, Greenfield); Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Medical University of South Carolina, Charleston, (Guille).

Constance Guille (C)

College of Nursing, Washington State University, Spokane, (Barbosa-Leiker); Program of Excellence in Addictions Research, Washington State University, Spokane, (Barbosa-Leiker); Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, (Campbell); Department of Psychiatry, McLean Hospital, Harvard Medical School, Boston, Massachusetts (McHugh, Greenfield); Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Medical University of South Carolina, Charleston, (Guille).

Shelly F Greenfield (SF)

College of Nursing, Washington State University, Spokane, (Barbosa-Leiker); Program of Excellence in Addictions Research, Washington State University, Spokane, (Barbosa-Leiker); Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, (Campbell); Department of Psychiatry, McLean Hospital, Harvard Medical School, Boston, Massachusetts (McHugh, Greenfield); Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Medical University of South Carolina, Charleston, (Guille).

Classifications MeSH